Coterra’s strong energy production allowed for big cash returns to shareholders

[ad_1] Coterra Energy missed Wall Street expectations for sales and earnings in the second quarter. However,…

Here’s why Amazon’s messy second quarter doesn’t change our outlook on the stock

[ad_1] Amazon shares are getting dinged on Thursday after its second-quarter sales missed expectations, despite a…

Apple’s earnings beat puts it on sure footing ahead of next month’s AI iPhone launch

[ad_1] Apple delivered quarterly beats after Thursday’s closing bell ahead of what’s expected to be a…

Solar stock Nextracker’s strong quarter is eclipsed by backlog concerns — here’s where we stand

[ad_1] Shares of Nextracker dropped in extended trading Thursday as questions about the solar technology firm’s…

Eaton shares get dragged down in the market selloff despite a nice beat and raise

[ad_1] Eaton on Thursday morning delivered quarterly beats on its top and bottom lines. Segment profit…

Meta shows aggressive spending on AI is already paying off in big earnings beat

[ad_1] Meta Platforms on Wednesday reported better than expected quarterly results, delivering revenue at the high…

GEHC gives reasons to look beyond temporary China woes and shares reverse higher

[ad_1] GE Healthcare on Wednesday morning reported a mixed second quarter and shares initially moved sharply…

Starbucks’ turnaround takes an encouraging step forward. Here’s what we want to see next

[ad_1] Starbucks served up better-than-feared quarterly results Tuesday night, sending shares of the coffee giant higher…

Lost in the market’s sharp rotation out of tech stocks is a really bullish call on major banks

[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable…

We’re encouraged by Abbott stock trading but discouraged by moves in Honeywell

[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable…

Jim Cramer’s advice on Abbott Labs stock after a nearly $500 million baby formula verdict

[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at…

We’re making a flurry of moves: trimming 2 stocks and buying 2 others that have lagged

[ad_1] We’re making four trades Monday morning. Shortly after the opening bell, we will be selling…

An ugly earnings report from a competitor is good news for Abbott Labs

[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at…

Here are 3 major reports that could drive the stock market in the week ahead

[ad_1] Wall Street finished higher for the holiday-shortened trading week, with tech stocks leading the way.…

FDA approval of Eli Lilly’s Alzheimer’s drug cements our decision not to take profits

[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable…

Newseum Global